These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 32736782)
1. Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia. Leader A; Gurevich-Shapiro A; Spectre G Thromb Res; 2020 Jul; 191 Suppl 1():S68-S73. PubMed ID: 32736782 [TBL] [Abstract][Full Text] [Related]
2. Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps. Leader A; Ten Cate H; Spectre G; Beckers EAM; Falanga A Crit Rev Oncol Hematol; 2018 Dec; 132():76-88. PubMed ID: 30447929 [TBL] [Abstract][Full Text] [Related]
3. [Which anticoagulant or antiplatelet treatment for cancer patients with thrombocytopenia ?]. Paoletti M; Azizi MA; Efthymiou A Rev Med Suisse; 2023 Feb; 19(813):281-285. PubMed ID: 36753345 [TBL] [Abstract][Full Text] [Related]
4. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482 [TBL] [Abstract][Full Text] [Related]
5. When and How to Combine Antiplatelet and Anticoagulant Drugs? Espinola-Klein C Hamostaseologie; 2022 Feb; 42(1):73-79. PubMed ID: 35196733 [TBL] [Abstract][Full Text] [Related]
6. Antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting. Lacoste JL; Hansen CL Am J Health Syst Pharm; 2019 Sep; 76(18):1395-1402. PubMed ID: 31505555 [TBL] [Abstract][Full Text] [Related]
11. Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention. Pareek M; Bhatt DL; Ten Berg JM; Kristensen SD; Grove EL Expert Opin Pharmacother; 2017 Jun; 18(9):875-883. PubMed ID: 28489475 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update. Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525 [TBL] [Abstract][Full Text] [Related]
13. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy. Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of combined antiplatelet and anticoagulant therapy: a critical review of the evidence from randomized controlled trials. Paikin JS; Wright DS; Eikelboom JW Blood Rev; 2011 May; 25(3):123-9. PubMed ID: 21354678 [TBL] [Abstract][Full Text] [Related]
15. Between Scylla and Charybdis: antithrombotic therapy in hematopoietic progenitor cell transplant patients. Deloughery TG Bone Marrow Transplant; 2012 Oct; 47(10):1269-73. PubMed ID: 21909143 [TBL] [Abstract][Full Text] [Related]
16. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Thompson PL; Verheugt FW Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant and antiplatelet therapy choices for patients with atrial fibrillation one year after coronary stenting or acute coronary syndrome. Olivier CB; Turakhia MP; Mahaffey KW Expert Opin Drug Saf; 2018 Mar; 17(3):251-258. PubMed ID: 29363352 [TBL] [Abstract][Full Text] [Related]